CHANGES OF 8-OXO-2'-DEOXYGUANOSINE LEVEL IN MOUSE LIVER CELLS DNA IN CASE OF ACUTE TOXIC STRESS

The changes of the 8-oxo-2'-deoxyguanosine (8-oxo-dG)/dG ratio in the DNA of laboratory mice hepatocytes under the influence of toxic stress were studied. It was shown that the injection of carbon tetrachloride causes the growth of 8-oxo-dG level. A rapid increase in the level of 8-oxo-dG in DNA occurs during the first day of the experiment at short-term toxic stress. Subsequently, 48 hours after the initial injection, the level of 8-oxo-dG decreases to the control values. This change in the value of the biomarker can be attributed to the activation of the reparative and antioxidant systems. The subsequent injection results again in an increase of 8-oxo-dG level, and the latter only increases thereafter. This reflects the exhaustion of the reparative potential of the organism and accompanies the progress of inflammation and pathological change of the liver tissue.

8-оксо-2'-дезоксигуанозин, induced cirrhosis, 8-oxo-2'-deoxyguanosine, biomarker of oxidative stress, reversedphase HPLC, electrochemical detection

1. Nevredimova T.S., Marmiy N.V., Esipov D.S., Esipova О.V., Shvets V.I. Vestnik MITHT (Fine Chemical Technologies). 2014. V. 9. № 5. P. 3–10. (in Russ.).

2. Roszkowski K., Jozwicki W., Blaszczyk P., Mucha-Malecka A., Siomek A. Med. Sci. Monit. 2011. V. 17. № 6. P. 329–333.

3. Lisitsyna T.A., Durnev A.D. Eksperimental'naia i klinicheskaia farmakologiia (Experimantal and Clinic Pharmacology). 1999. V. 62. P. 38–41. (in Russ.).

4. Haghdoost S., Maruyama Y., Pecoits-Filho R., Heimburger O, Seeberger A., Anderstam B., Suliman M.E., Czene S, Lindholm B, Stenvinkel P., HarmsRingdahl M. Antioxidants & Redox Signaling. 2006. V. 8. № 11-12. P. 2169–2173.

5. Svecova V., Rossner P.J., Dostal M., Topinka J., Solansky I., Sram R.J. Mutation Research / Fundamental and Molecular Mechanisms of Mutagenesis. 2009. V. 662. № 1. P. 37–43.

6. Dorszewska J., Florczak J., Rozycka A., Kempisty B., Jaroszewska-Kolecka J., Chojnacka K., Trzeciak W.H., Kozubski W. Acta Neurobiol. Exp. (Wars). 2007. V. 67. № 2. P. 113–129.

7. Hamilton M.L., Van Remmen H., Drake J.A., Yang H., Guo Z.M., Kewitt K., Walter C.A., Richardson A. Proc. Nat. Acad. Sci. USA. 2001. V. 98. № 18. P. 10469–10474.

8. Haghdoost S., Czene S., Näslund I., Skog S., Harms-Ringdahl M. Free Radical Research. 2005. V. 39. Is. 2. P. 153–162.

9. Huh J.Y., Son D.J., Lee Y., Lee J., Kim B., Lee H.M., Jo H., Choi S., Ha H., Chung M.H. Free Radic. Biol. Med. 2012. V. 53. № 1. P. 109–121.

10. Kim D.H., Cho I.H., Kim H.S., Jung J.E., Kim J.E., Lee K.H., Park T., Yang Y.M., Seong S.Y., Ye S.K., Chung M.H. Experimental & Molecular Medicine. 2006. V. 38. № 4. P. 417–427.

11. Ock C.Y., Kim E.H., Choi D.J., Lee H.J., Hahm K.B., Chung M.H. World J. Gastroenterol. 2012. V. 18. № 4. P. 302–308.

12. Hong G.U., Kim N.G., Jeoung D., Ro J.Y. J. Neuroimmunol. 2013. V. 260. № 1. P. 60–73.

13. Kim J.S., Kim D.Y., Lee J.K., Ro J.Y., Chung M.H. Eur. J. Pharmacol. 2011. V. 651. № 1. P. 218–226.

14. Hong G.U., Kim N.G., Ro J.Y. Radiat. Res. 2014. V. 181. № 4. P. 425–438.

15. Unnikrishnan A., Prychitko T.M., Patel H.V., Chowdhury M.E., Pilling A.B., Ventrella-Lucente L.F., Papakonstantinou E.V., Cabelof D.C., Heydari A.R. Free Radic. Biol. Med. 2011. V. 50. № 2. P. 270-280.

16. Nevredimova Т.S., Klyus К.А., Marmiy N.V., Nalobin D.S., Chernysheva М.B., Vasilegina Yu.I., Suprunenko Е.А., Bespyatykh А.Yu., Esipov D.S. Study of the protective effect of melatonin on the model of induced liver cirrhosis by analyzing the content of 8-oxo-2'-deoxyguanosine / X Int. Symp. "Biological mechanisms of aging": a collection of abstracts. May 16–19, 2012, Kharkov, Ukraine. Kharkov: Kharkov State University Publ., 2012. P. 45. (in Russ.).

17. Lieber C.S. Advances in Pharmacology. 1997. V. 38. P. 601–628.

18. Esipov D.S., Sidorenko Е.V., Esipova О.V., Gorbacheva Т.А., Nevredimova Т.S., Krushinskiy А.L., Kuzenkov V.S., Reutov V.P. Vestnik MITHT (Fine Chemical Technologies). 2010. V. 5. № 3. P. 69–74. (in Russ.).

19. Ingawale D.K., Mandlik S.K., Naik S.R. Environmental Toxicology and Pharmacology. 2014. V. 37. № 1. P. 118–133.

20. Menshikova E.B, Lankin V.Z., Zenkov N.K., Bondar I.A., Krugovih N.F., Trufakin V.A. Oxidative stress. Pro-oxidants and antioxidants. Moscow: Slovo Publ., 2006. 556 p. (in Russ.).

21. Glebova K., Veiko N., Kostyuk S., Izhevskaya V., Baranova A. Cancer Lett. 2015. V. 356. № 1. P. 22–33.

22. Chernysheva M.B. , Vasilegina Y.I., Nalobin D.S., Klyus K.A., Nevredimova T.S., Marmiy N.V., Suprunenko E.A., Bespyatykh A.Yu., Esipov D.S. Study of the protective effect of melatonin on the model of induced liver fibrosis: histologic evaluation / X Int. Symp. "Biological mechanisms of aging": a collection of abstracts. May 16–19, 2012, Kharkov, Ukraine. Kharkov: Kharkov State University Publ., 2012. P. 64. (in Russ.).

23. Satyam Nampalli, Shiva Kumar. Bioorganic & Med. Chem. Lett. V. 10. Is. 15. P. 1677–1679.